 |
Etidronate disodium |
|---|---|
| Trade Name | Didronel Iv Infusion |
| Orphan Indication | Degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition |
| USA Market Approval | USA |
| USA Designation Date | 1991-05-02 00:00:00 |
| Sponsor | MGI Pharma, Inc.;6300 West Old Shakoppe Rd., Suite 110;Bloomington, Minnesota, 55438 |
